Translation of "Cerebral ischemia" in German

Manual stretching and twist of the neck provoking cerebral ischemia.

MRI didn't indicate any cerebral ischemia.

Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia.

The antioxidative effect of saffron reduces the effects of a cerebral ischemia (cerebral infarction following oxygen deprivation).

I had contracted rheumatism, tracheitis, heart disease and cerebral ischemia, among other conditions.

Magnetic resonance imaging showed cerebral ischemia in the area supplied by the posterior cerebral artery.

These promising results might facilitate the treatment of cerebral ischemia or nerve injury.

Others thought she had a stroke, intermittent cerebral ischemia, allergies, or asthma.

The diagnosis should therefore be considered in any patient who develops new neurological symptoms that are consistent with cerebral ischemia during methylphenidate therapy.

The MAH review of post-marketing spontaneous data found that cerebrovascular events from spontaneous reports consisted mainly of the reported terms: cerebrovascular accident, stroke, cerebral infarction and cerebral ischemia as well as a few reports of other events.

Serious, sometimes fatal, arterial thromboembolic events (ATEs) including myocardial infarction, cardiac arrest, cerebrovascular accident, and cerebral ischemia have been reported in clinical studies.

I have run every test, checked for cerebral ischemia by monitoring microcirculatory blood flow,

For reason of their vasospasmolytic effects the compounds are mainly indicated for the treatment of cerebral, cardiac, and peripheral vascular diseases such as myocardial ischemia, cerebral infarction, pulmonary thromboses, as well as in cases of arteriosclerosis and other stenotic symptoms.

For reason of their vasospasmolytic effects these compounds are mainly indicated for the treatment of cerebral, cardiac, and peripheral vascular diseases such as myocardiac ischemia, cerebral infarction, pulmonary thromboses, as well as in cases of arterioschlerosis and other stenotic disorders.

In Wistar rats with gravitational cerebral ischemia, Phenylpiracetam reduced the extent of neuralgic deficiency manifestations, retained the locomotor, research, and memory functions, increased the survival rate, and lead to the favoring of local cerebral flow restoration upon the occlusion of carotid arteries to a greater extent than did piracetam.

For reason of their vasospasmolytic effects these compounds are mainly indicated for the treatment of cerebral, cardiac, and peripheral vascular diseases such as myocardiac ischemia, cerebral infarction, pulmonary thromboses, as well as in cases of arteriosclerosis and other stenotic disorders.

Preferred medical applications of this preparation of the invention comprise the production of a preparation for improving the perfusion or micro-circulation, preferably in vital organs, such as, e.g., in the brain (cerebral ischemia), in the heart (myocardial infarct), in the kidneys, in the liver or in the extremities, or in the entire organism, respectively.

The compounds of the present invention provide a novel therapeutic potential for the treatment of hypertension, pulmonary hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, endotoxin-induced organ failure, intravascular coagulation, restenosis after angioplasty, benign prostate hyperplasia, or hypertension or kidney failure caused by ischemia or intoxication, and cancers, especially prostate and skin cancer.

The compounds can also be used in endocrinology and gynecology, e.g., for the therapeutic treatment of acromegaly, hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation, and also for the prophylaxis and therapy of cerebral disorders (e.g., migraine), especially in geriatrics in a manner similar to certain ergot alkaloids and for controlling the sequelae of cerebral infarction (apoplexia cerebri), such as stroke and cerebral ischemia.

It is known that as a consequence of a cerebral ischemia glutamate is liberated in major quantities, and inter alia binds to the NMDA receptor complex and is responsible for an increased input of calcium and to an increased release of intracellular calcium into the neuronal cells.

Consequently, their application is recommended primarily in cerebral, cardiac and peripheral vascular diseases, such as myocardial ischemia, cerebral hemorrhage, cerebral infaraction, temporary cerebral vascular dysfunction, atherosclerosis, renal arteriostenosis and various further stenotic conditions.

The novel compounds are therefore suitable for the treatment of cardiovascular disorders, in particular coronary heart disease, vasospasms, cerebral ischemia, hypertension and circulatory shock.